Siemens Medical successfully listed on the Frankfurt Stock Exchange, the stock price rose nearly 4%, 29.31 euros ($35.86) per share, and its issue price is 28 euros per share.
It is understood that Siemens Healthcare's IPO issued 150 million shares, accounting for about 15% of the company's common stock, raising 4.2 billion euros ($5.2 billion). (Financing will be used for future acquisitions and investments of the company, thereby enhancing The independent value of Siemens Healthcare, which also makes its IPO one of the largest IPOs in Germany in the past 20 years, and is one of the largest IPOs in Europe this year.
At present, the market value of Siemens medical care is about 26 billion to 31 billion euros, lower than the initial forecast of 40 billion euros. According to analysts, the main reason is market volatility and the uncertainty of the company's new product Atellica.
Siemens Medical's listing plan was first launched in 2016 and is part of Siemens's CEO Kezer's efforts to restructure and simplify the company's structure. This will provide investors with a stake in Siemens' business. Opportunities, while providing funding for business expansion. Siemens has said that the promotion of the medical business is a crucial first step, the overall goal is to enable Siemens to acquire start-ups that are developing new medical and diagnostic technologies and services, especially in the United States.
According to Siemens' 2017 financial report, Siemens Medical is one of Siemens' most profitable businesses. In FY2017, Siemens Group's total revenue was 83.049 billion euros and net profit was 6.179 billion euros. Siemens medical revenues reached 13.79 billion euros, with a profit of 2.49 billion euros, accounting for 40% of the total net profit of the Siemens Group, the highest among all businesses. In terms of region, more than half of Siemens Healthcare's revenue growth in FY2017 came from China; in terms of business, its growth was mainly driven by the medical imaging diagnostics business.
According to industry sources, the launch of Siemens Healthcare will enable the healthcare company to invest in research-intensive areas, such as molecular diagnostics, which will allow it to grow faster.
With the development of the times, the consumption level of people is gradually increasing. At the same time, people's entertainment methods are beginning to diversify, especially for modern young people. As a result, different kinds of electronic products are starting to be in people's lives, and the booming Electronic Cigarette industry reflects this.
Described including the upper shell, the upper shell at the top of the smoke outlet, as described in the bottom of the upper shell with airway, described with the smoke outlet in the airway and also to match the upper shell, the lower part of the shell described the airway in the direction of the lower shell extension, as described in the lower shell near one end of the upper shell is equipped with oil mouth, described the lower shell with batteries, described at the bottom of the bottom shell has come in The air port is provided with an oil storage bin in the lower shell, and the air passage passes through the oil storage bin and is provided with a heating atomization bin at one end away from the smoke outlet. The utility model has beneficial effects: it can meet the smoking habit of different users, avoid the premature end of the use experience caused by excessive consumption of smoke oil, and indirectly prolong the service time and life of the product.
Refillable E-Cig Oem,Refillable Vape Pod,Refillable Vape Pen Oem,Refillable Mod Oem
Shenzhen MASON VAP Technology Co., Ltd. , https://www.cbdvapefactory.com